| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.1 | 0.1 | 0.1 |
| Total income | 0.1 | 0.1 | 0.1 |
| Profit before exceptional items & tax | -0.0 | 0.0 | 0.0 |
| Profit before tax | -0.0 | 0.0 | 0.0 |
| Net profit | -0.0 | 0.0 | 0.0 |
| Operating margin | 0.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +0.00% |
|---|
BSE results filing, NSE: OMKARPH. Figures extracted from the filing.
Omkar Pharmachem Ltd: key numbers
- Share price
- ₹9.58
- Market cap
- ₹9.66 Cr
- Revenue (annual)
- ₹0.46 Cr
- Net profit (annual)
- ₹0.12 Cr
- P/E (TTM)
- 113.4×Sector 37.5×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omkar Pharmachem Ltd
All →Omkar Pharmachem Annual Report
Omkar Pharmachem Ltd has submitted its 31st Annual Report and Notice for the Annual General Meeting scheduled for September 30, 2026. The agenda includes approving audited accounts.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Ltd has scheduled its 31st Annual General Meeting for September 30, 2026. Key agenda items include adopting financial statements and approving material related party transactions.
- Execution
- FY 2026-27
Omkar Pharmachem Q4 FY26 Results: Net Profit ₹0 Cr
Omkar Pharmachem Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q4 FY26.
- Key figure
- Net profit ₹0 Cr